Home › Funds › Cormorant Asset Management, LP › EWTX

Cormorant Asset Management, LP position in EWTX

EDGEWISE THERAPEUTICS INC · Health Care

Cormorant Asset Management, LP reported holding 2,510,000 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$102.0M, representing 5.23% of its reported portfolio and ranking #6 among its reported holdings. Cormorant Asset Management, LP has disclosed EWTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.51M sh
Reported value held$101.98M
Portfolio Weight5.23%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's EWTX position evolved

Cormorant Asset Management, LP first disclosed a stake in EWTX in Q3 2023 at 2,946,887 shares (US$16.9M). The position peaked in Q1 2026 at 3,260,000 shares, worth US$102.7M. Across 12 filings, Cormorant Asset Management, LP increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 2,510,000 shares valued at US$102.0M — a reduction of -750,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.95M $16.89M New
Q4 2023 2.55M $27.92M Reduce
Q1 2024 3.01M $54.84M Add
Q2 2024 3.01M $54.15M Hold
Q3 2024 3.41M $90.92M Add
Q4 2024 3.41M $90.95M Hold
Q1 2025 4.10M $90.24M Add
Q2 2025 4.25M $55.74M Add
Q3 2025 4.01M $65.04M Reduce
Q4 2025 3.29M $81.52M Reduce
Q1 2026 3.26M $102.69M Reduce
Q2 2026 2.51M $101.98M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EWTX and 13F data

EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EWTX

All EWTX fund holders →

FAQ

How long has Cormorant Asset Management, LP held EWTX?

Cormorant Asset Management, LP has disclosed EWTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Cormorant Asset Management, LP's current position in EWTX?

As of Q2 2026, Cormorant Asset Management, LP holds 2.51M shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $101.98M, representing 5.23% of its reported portfolio and ranking #6.

Has Cormorant Asset Management, LP been buying or selling EWTX?

In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP reduced its position in EWTX. The position peaked in Q1 2026 at 3.26M shares.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.